Your session is about to expire
← Back to Search
Nature Sounds for Breast Cancer
N/A
Waitlist Available
Led By Kirti Kulkarni, MD
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
≥ 21 years old
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from the start of procedure until the end, not to exceed 2 years.
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether or not continuous exposure to non-verbal support (NS) during a chemotherapy-induced nausea and vomiting (CINV) procedure helps to reduce the severity of symptoms experienced. Patients will be randomly assigned to either the NS group or a control group who will receive standard care (supportive dialogue).
Who is the study for?
This trial is for individuals aged 21 or older who are undergoing a breast core biopsy (CNB) and can read and speak English. Participants must provide written consent to join the study.
What is being tested?
The study is testing if listening to nature sounds (NS) during CNB can help reduce pain and anxiety compared to standard care, which involves supportive dialogue. Patients will be randomly placed in either the NS group or the standard care group.
What are the potential side effects?
Since this trial involves listening to nature sounds, there are no direct medical side effects expected. However, individual reactions to sound therapy may vary.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 21 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from the start of procedure until the end, not to exceed 2 years.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from the start of procedure until the end, not to exceed 2 years.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Measure of physiologic stress of patients and staff
Measure of psychologic stress of patients and staff
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Nature sounds exposureExperimental Treatment1 Intervention
Patients will be randomly assigned to either the nature sounds group or the standard care group.
Patients in the nature sounds group will be exposed to continuous nature sounds during the core needle biopsy (CNB) procedure.
The CNB procedure will continue as planned with nature sounds playing instead of the supportive dialogue. All sounds will be played out of a speaker situated in the corner of the room.
Group II: Standard care (supportive dialogue)Active Control1 Intervention
Patients will be randomly assigned to either the nature sounds group or the standard care group.
The CNB procedure will continue as planned with supportive dialogue which will be played out of a speaker situated in the corner of the room. This group follows the current standard of care.
Find a Location
Who is running the clinical trial?
University of ChicagoLead Sponsor
1,062 Previous Clinical Trials
839,934 Total Patients Enrolled
25 Trials studying Breast Cancer
4,559 Patients Enrolled for Breast Cancer
Kirti Kulkarni, MDPrincipal InvestigatorUniversity of Chicago
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 21 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Nature sounds exposure
- Group 2: Standard care (supportive dialogue)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.